 DARTMOUTH, Nova Scotia--BUSINESS WIRE--- IMV Cancer--IMV Inc. IMV or the Corporation Nasdaq: IMV; TSX: IMV, a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, will hold its 2021 annual and special meeting of shareholders the Meeting by way of a Virtual only meeting on Friday, June 18, 2021 at 11:00 am Eastern Daylight Time We are pleased to announce that the two leading independent proxy advisory firms that pro 